ARTG Entry

ERLOTINIB CIPLA

ARTG entry for ERLOTINIB CIPLA (erlotinib), ARTG 337797 — Product Information, dosage form, registration history. Compiled by arcimedes.

• Sponsor: Cipla
• Active ingredient: erlotinib
• Therapeutic area: Oncology

TGA Public Summary — ARTG 337797